Clinical trial

Adderall XR and Processing Speed in Multiple Sclerosis (MS)

NCT01667484

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-09-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2012-09-01Date precision: month

Registry last updated2015-05-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Impaired Processing Speedunresolved

Cognitive Impairmentunresolved

Multiple Sclerosisunresolved

Interventions

Adderall XR 5mgDRUG

Adderall XR 10 mgDRUG

Sponsors & collaborators

London Health Sciences Centrelead sponsor

Mapped research locations

LondonOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01667484 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.